Adolescents and young adult cancer patients (AYACP) with terminal diagnoses face the challenge and additional burden of planning their end-of-life (EoL) care. Although AYACP receive a standard-of-care at EoL, the care they receive may not align with their goals. As such, the characteristics of their goals-of-care are poorly understood.

Lymphomas are one of the primary cancers that affect adolescents and young adults (AYAs). We examined the feasibility of two group-based interventions-one meditation-based and one education-based-for AYAs with lymphoma. We also explored their potential benefits for reducing psychological distress and cancer-related symptom burden.

In the context of cancer, pain demands interpretation. Our research has found that fear of cancer recurrence (FCR) is associated with the tendency to interpret ambiguous information as health-related. We aimed to determine whether we could modify these interpretation biases to improve FCR, and pain outcomes.

Rural residents are more likely to be caregivers and face significant burdens in caring for cancer patients. Rural caregivers can benefit from tailored interventions addressing their unique and complex needs.

This study aimed to identify individual variability in day-to-day physical activity (PA) and sedentary behavior (SB) as well as effects of pain, fatigue, and well-being among patients with head and neck cancer (pwHNC) on both movement behaviors.

Depression is a common psychological disorder in patients with cancer. Exercise intervention has been demonstrated as an effective non-pharmacological intervention for improving depression. However, the relative efficacy of different types of exercise interventions remains uncertain.

Sarcoma is a rare cancer with complex treatment phases, leaving people with sarcoma and their carers with unmet information and support needs. This review provides an evaluation of sarcoma websites internationally to inform the development of online resources for the SUN-SHINE sarcoma project, aimed at addressing the unmet needs of people with a sarcoma diagnosis.

Fear of cancer recurrence (FCR) is a major psychological burden for breast cancer survivors, impairing daily functioning and quality of life. Fear of Recurrence Therapy (FORT), a cognitive-behavioral group intervention, has shown efficacy in Western settings. This study evaluated the effectiveness of an adapted FORT program in Turkish breast cancer survivors.

This study aims to integrate existing qualitative research, consolidate the dynamic experiences of parents of adolescent cancer patients regarding fertility preservation (FP), and highlight the influencing factors of parents' decisions on FP.

Depression significantly impacts quality of life and prognosis in subjects with cancer. Despite the evidence supporting the role of pharmacotherapy, real-world data on the effectiveness and tolerability of different antidepressant classes in cancer populations remain limited.

Cancer patients who receive the information that they need may experience better quality of life and emotional wellbeing, and be more equipped to engage in shared decision-making. Our review explores the information needs of haematological malignancy patients specifically, and their experience of the information process.

This study identified psychological empowerment profiles of women with breast cancer to provide a clinical care framework.

Exercise has been shown to improve mental well-being and health-related quality of life (HRQoL) in breast cancer survivors. However, there is no evidence on the effects of online interventions tailored using heart rate variability (HRV).

Despite the importance of follow-up care for childhood cancer survivors (CCS), adherence remains below recommended levels. Potential barriers include geographical distance. We aimed to improve our understanding of the accessibility of survivorship follow-up care at a Long Term Survivor Clinic (LTSC).

Patients with cancer increasingly engage in online health information seeking (OHIS), yet the impact thereof on their anxiety and uncertainty remains unclear. This study aimed to: (1) examine how, when, and why patients engage in OHIS before and after oncological consultations; (2) identify patient characteristics (sociodemographic, medical, psychological) associated with OHIS; and (3) explore the relationship between OHIS, state anxiety, and uncertainty.

Professional grief refers to the emotional response healthcare professionals may experience following patient deaths. Although likely relevant in clinical practice, this phenomenon has been overlooked in research-particularly among psycho-oncologists. This study examined the emotional impact, coping strategies, and support needs related to professional grief in a German sample of psycho-oncologists.

Young and middle-aged cancer patients often face unique challenges, which may trigger their reflection and inquiry into the meaning in life. Patients from different cultural backgrounds and life stages may have varied experiences and perceptions of meaning in life, making it necessary to explore this further.

Distress affects about one-third of people with cancer, yet many never want, seek, or receive mental health care. Identifying the barriers that distinguish those who obtain help from those who do not can guide service design in psychosocial oncology.

Mindfulness-Based Interventions (MBIs) are recognized as beneficial in oncology supportive care. While qualitative analyses of mindfulness program experiences exist, this is the first mixed methods study to examine patients' experiences after participating in the online Mindfulness-Based Cancer Recovery (e-MBCR) program.

This study investigated the course of general well-being and health-related quality of life (HRQoL) in working-age melanoma patients during the first year following diagnosis. It also examines the use of psycho-oncological counseling and rehabilitation, and their impact on QoL.

Three subgroups of adolescent and young adult patients (AYAs; 18-39 at diagnosis) with an uncertain or poor cancer prognosis (UPCP-those diagnosed with advanced disease, who will likely die prematurely) were previously identified: those receiving traditional treatments (chemotherapy and/or radiotherapy), newer treatments (immunotherapy or targeted therapy), and patients with glioma. This study examines differences in health-related quality of life (HRQoL) among these subgroups, and comparisons between AYAs with a UPCP, recently diagnosed AYAs, and a healthy control group.